Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Healthcare

Gilead Targets Remdesivir Supply For Two Million COVID-19 Patients By Year-End

Gilead's expectations of two million treatment courses suggests sales of between $2 billion and $3 billion between 2020 and 2021 at a price of $1,000 to $2,000 per course

Read More

GSK In Quest To Be Best, Not First, In Race For COVID-19 Vaccine

GSK is one of more than 100 global players working on vaccines against COVID-19, which has killed about 350,000 people.

Read More

Alembic Pharma Gets EIR From USFDA For Its Panelav Facility

Shares of Alembic Pharmaceuticals were trading at Rs 940.05 per scrip on the BSE, up 3.50 per cent from its previous close.

Read More

Glenmark Pharmaceuticals Gets USFDA Nod For Fingolimod Capsules

Shares of Glenmark Pharmaceuticals were trading at Rs 411.20 a piece on BSE in morning trade, up 1.44 per cent from their previous close.

Read More

Dexamethasone: Is This Drug Saving Covid-19 Patients?

The report by Oxford University stated the recovery of more than 11,500 patients, enrolling in over 175 hospitals across the UK.

Read More

France Expects AstraZeneca COVID-19 Vaccine To Be Shared Pro Rata

The British drugmaker signed a contract with European governments at the weekend to supply the region with up to 400 million doses of its potential vaccine.

Read More

COVID-19 Cure Possible Through Ayurveda, Patanjali Case Study Showed 100 % Favorable Results, Claims Acharya Balkrishna

India's COVID-19 tally on Saturday witnessed its highest-ever spike of 11,458 cases, according to the Union Ministry of Health and Family Welfare (MoHFW).

Read More

India Lifts Export Ban On Trump-Touted Drug Hydroxychloroquine

Manufacturers, except export-oriented units and those in special economic zones, would still have to supply 20% of their production to the domestic market,

Read More

Indian Firm Panacea Says Aiming To Make COVID-19 Vaccine

Panacea's shares jumped 20% in morning trading on India's National Stock Exchange after the news.

Read More

AstraZeneca Wins Fresh US Backing In Race For COVID-19 Treatment

Companies and governments are scrambling to bring a solution for the illness caused by the new coronavirus to market as soon as possible

Read More

AstraZeneca Contacted Gilead Over Potential Megamerger

Gilead, AstraZeneca and other drugmakers, including Eli Lilly and Co, Pfizer and Merck & Co, are racing to develop vaccines or treatments for COVID-19

Read More

Sun Pharma Testing Plant-based Drug As Potential COVID-19 Treatment

The company said the trial will be conducted across 12 centers in India in 210 patients and a human safety study of the drug has been completed.

Read More

China's Wuhan Discharges Last 3 Covid-19 Patients From Hospital

As of Wednesday, Wuhan had 245 people with asymptomatic symptoms were under quarantine.

Read More

Covid-19: 'Want To Know If Private Hospitals Ready To Charge At Ayushman Bharat Rates,' Asks SC

The 'Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana' is aimed at providing health cover to poor and vulnerable persons in the country.

Read More

Sun Pharma Initiates Phase Two Clinical Trial On AQCH As Potential Treatment For COVID-19 Patients

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and India's top pharmaceutical company.

Read More